ABSTRACT. An increase in lipid peroxidation has been reported in fetal human trisomy 21 brains. To determine whether this change can be regarded as a consequence of the increase in soluble Cu, Zn-superoxide dismutase (SOD-1) activity caused by the trisomy, we have made use of the trisomy 16 mouse, a model for human trisomy 21. Lipid peroxidation, as malonaldehyde, and the activities of SOD-1 and glutathione peroxidase were studied in diploid and trisomy 16 mouse fetuses and fetal brains and, for comparison, in diploid and trisomy 21 human fibroblasts. SOD-1 activity in diploid mouse brain increased during fetal and postnatal development, but glutathione peroxidase activity was unchanged. Mean SOD-1 activity was almost exactly 50% increased in trisomy 16 fetuses and fetal brains and in human trisomy 21 fibroblasts, confirming the gene dosage effect in both species. The SOD-1 activity in the trisomic fetuses was correlated with that in their matched diploid littermates, suggesting that factors other than the gene dosage also determine activity. Mean glutathione peroxidase activity was not increased in trisomy 16 fetuses or brains and only slightly increased in human trisomy 21 fibroblasts. Mean lipid peroxidation was decreased in fetal trisomy 16 brains but was increased in human trisomy 21 fibroblasts. These results do not lend support to the notion that increased SOD-1 activity is developmentally deleterious and necessarily increases lipid peroxidation and, secondarily, the activity of glutathione peroxidase. The difference between the human and mouse data concerning lipid peroxidation in trisomic brains may be related to structural differences in the lipids which provide the substrate for lipid peroxidation. (Pediatr Res 21: 88-92,1987) Abbreviations DS, Down syndrome SOD-1, soluble superoxide dismutase, Cu, Zn-superoxide dismutase GSH-Px, glutathione peroxidase
MDA, malonaldehyde TBA, thiobarbituric acid PUFA, polyunsaturated fatty acids 02-, superoxide H202, hydrogen peroxide OH., hydroxyl radical NBT, nitroblue tetrazolium Chemically reactive oxygen radicals and compounds, including 02-, H202, and OH., are generated during normal cellular metabolism and after exposure to external agents such as radiation and certain chemicals. All living cells exposed to oxygen have enzymatic systems for protection against activated oxygen, and SOD-1 and GSH-Px are members of these systems. SOD-1, a soluble Cu-Zn enzyme, is coded for by human chromosome 21, and individuals with DS have a 50% increase in SOD-1 activity. Among the cells and tissues studied have been erythrocytes (I), fibroblasts (2) , platelets (3), lymphocytes (2) , and fetal brain (4) .
SOD-1 catalyses the dismutation of 0 2 -to form H202 which, in turn, is reduced to water by catalase and peroxidases, especially GSH-Px. However, H202 can also react with 02-to generate the hydroxyl radical which may be the most injurious of the oxygen metabolites. Because of the central role of SOD-1 in the generation of H202, it has been suggested that the increased SOD-l activity in human trisomy 21 could result in an increased generation of H202 and, as a consequence, in increased lipid peroxidation (5, 6) . Lipid peroxidation has been implicated in the causation of damage to membrane and other cellular structures with high contents of unsaturated lipids, thereby leading to progressive tissue damage. The most vulnerable organ is probaly the nervous system, which contains a high content of PUFA, and it has been proposed that the appearance of mental retardation and presenile dementia in DS is brought about, in whole or in part, by increased lipid peroxidation in the brain (5, 6) . As evidence in support of this idea, Sinet and coworkers (3, 5) and Annertn et al. (7) demonstrated an increase in the activity of GSH-Px, an inducible enzyme coded for by human chromosome 3, in trisomy 2 1 erythrocytes and lymphoid cells. Such increases have also been shown by Frischer et al. (8) , Ntve el al., (9) and Bjorksttn et al. (10) (2) . Furthermore, Mayes et al. (12) claimed that cell death and lipid peroxidation were increased in trisomy 21 fibroblasts exposed to high oxygen tension, and Elroy-Stein et al. In a recent study, Brooksbank and Balazs (4) reported a 50% elevation in lipid peroxidation in the brains of human fetuses with trisomy 21 as compared with controls. However, because the trisomic brains had an increased ratio of n-3 to n-6 fatty acids compared to diploid brains (14) , the significance of the observed increase in lipid peroxidation is uncertain. Furthermore, in contrast to the results obtained using erythrocytes and lymphoid cells mentioned above, GSH-Px activity was not increased in the fetal brain.
The detailed analysis of the development and biochemistry of the aneuploid human brain is, for many reasons, very difficult, and we have therefore made use of animal model systems to study the pathogenesis of the effects of chromosome imbalance (1 5, 16). Of particular interest with regard to human trisomy 21 is the trisomy 16 mouse fetus which, because several loci which map to human chromosome 21 are located on chromosome 16 in the mouse, serves as an animal model of the human trisomy (1 7). These loci include superoxide dismutase-1 (SOD-1 ) (1 8, 19) , the interferon-a/@ receptor (IFNRA or IFRC) (18, 19) , phosphoribosylglycinamide synthetase (PRGS) (20) , and the oncogene ETS2 (21) . Mouse fetuses with trisomy 16 survive until 18-19 days of gestation and have been used for a variety of studies on cardiac, immunological, and neurological development (22) (23) (24) (25) (26) .
The aim of the present study was to investigate lipid peroxidation and the activity of SOD-1 and GSH-Px in trisomy 16 fetuses, especially in the brain, so as to determine whether the changes in lipid peroxidation observed in fetal human trisomy 2 1 brains can be regarded as a general effect of elevated SOD-1 activity. Since there are developmental delays in trisomy 16 fetuses compared to diploid littermates (27) , the developmental variation in SOD-1 and GSH-Px activities in normal diploid mouse brain of different gestational ages was also evaluated. In addition, in order to compare the results in mouse trisomy 16 with those in human trisomy 21, the activities of SOD-1 and GSH-Px and the amount of lipid peroxidation were studied in matched sets of human trisomy 2 1 and diploid fibroblasts.
MATERIALS AND METHODS
Breeding of mice andpreparation of tissues. Male mice, doubly heterozygous for two different Robertsonian translocation chromosomes, Rb(16.17)32Lub and Rb(11.16)2H, each of which contains chromosome 16 within a metacentric chromosome, were mated to superovulated CD1 female mice containing a normal set of acrocentric chromosomes to generate trisomy 16 fetuses and littermate controls (23, 28) . After 14 or 17 days of gestation, the pregnant mice were sacrificed and the trisomic fetuses were identified by their phenotypic abnormalities, including reduced size and massive edema (17) . The whole embryo or fetal brain was homogenized in ice-cold Tris-HC1 buffer (50 nM, pH 7.6) at a tissue to buffer ratio of 19: 1 (w/v) (2-4 mg protein/ ml). Protein was measured according to the method of Lowry et a/. (29) .
Fibroblast cultures. The fibroblast stains used have been previously described (30) . They were obtained from skin biopsies or autopsy specimens of fetuses and were stored at -160" C prior to use. Strains 306 (trisomic) and 307 (diploid) were derived from siblings, strains 255 (diploid) and 256 (trisomic) were derived from a pair of unrelated aborted fetuses matched for gestational age, and strains 152 (diploid) and 153 (trisomic) were from aborted fetal dizygotic twins. Cells were grown in Dulbecco modified Eagle medium (Gibco, Grand Island, NY) containing 10% fetal calf serum, gentamycin (0.1 ml/ 100 ml), and glutamine (1 m1/100 ml) in 5%C02 at 37" C. The cells were harvested at 70-100% confluence and were washed three times in saline solution.
SOD-1 assays. SOD-1 was assayed for its ability to inhibit the superoxide-mediated reduction of NBT according to the method of Salin and McCord (3 1) and Fried (32) . The reaction mixture, in a total volume of 300 p1, consisted of 0.02 M sodium bicarbonate (pH 10.0), 0.013 mM xanthine 3 pM phenazaine methosulphate, 27 pM nitroblue tetrazolium, and 20 to 30 p1 of cell supernatant. The assay was started by adding 10 p1 xanthine oxidase at an appropriate dilution to give a change in absorbance of 0.024 to 0.036 OD U/min. Absorbance was measured at 41 8 nm with a Gilford Response spectrophotometer, and the SOD-1 concentration was expressed as U/mg of total protein. One unit of enzyme activity is defined as that amount which causes a 50% inhibition in the NBT reduction rate. GSH-Px assays. GSH-Px activity was assayed by a modification of the method of Paglia and Valentine (33) . Reduced glutathione was oxidized by GSH-Px, using cumene hydroperoxide as substrate. The oxidized glutathione was then enzymatically regenerated to the reduced form by glutathione reductase and NADPH. Reaction rates were followed by continuously measuring the decrease in NADPH concentration spectrophotometrically at 340 nm at 37°C. The GSH-Px activity was expressed as mU/mg of total protein against a bovine GSH-Px standard (Sigma G 6 137).
Lipid peroxidation assays. Lipid peroxidation was estimated from the formation of MDA which, together with TBA, forms a colored product (34) . Most of the MDA measured in the TBA test is formed from fragmentation of lipid peroxides during incubation at 37°C in the presence of ascorbic acid and an iron salt. Baseline values reflect the levels of free MDA and other products present in the sample that absorb at or close to 532 nm (35) . Duplicate samples of 300 p1 homogenized brain tissue in 50 mM ice-cold Tris-HC1 (pH 7.6) were placed on ice. One of the samples was incubated in a 37°C shaking-bath for 30 min after adding ascorbic acid and FeS04 (250 and 10 pM final concentrations, respectively). Baseline levels were obtained by determining the levels ofTBA chromogens in samples not treated with heat, ascorbic acid, and ferrous sulphate. To the baseline and incubated samples, H 2 0 (0.9 ml) and 28% (w/v) trichloroacetic acid (0.6 ml) were immediately added, and the mixtures were centrifuged at once at 3000 x g for 15 min at 2" C. The supernatant, 1.38 ml, was mixed with 230 p1 of 1% TBA (w/v in 50 mM NaOH) solution and incubated at 100" C for 15 min. Absorbance was measured at 532 nm, and the TBA chromogen concentration was expressed as nmol MDA/mg total protein against a standard of malonaldehyde tetraethylacetal (Sigma).
RESULTS
SOD-I and GSH-Px activities in fetuses. The developmental changes in activities of SOD-1 and GSH-Px in the brains of normal diploid mice from 14 days of gestation to adulthood are shown in Figure 1 . While SOD-1 activity increased about 100% during the last week of gestation ( p < 0.001) and then again about 20% between 4 wk and 2 3 months after birth, GSH-Px activity did not change significantly over the entire period. There were no changes in the SOD-1 or GSH-Px activities between 14 and 17 days of gestation, and this made it possible to compare the results in trisomy 16 fetal brain, which was somewhat delayed in development, with those in diploid fetal littermate brain.
A comparison of SOD-1 and GSH-Px activities in trisomy 16 and diploid fetuses is shown in Table 1 . As expected from the increase in SOD-1 gene dosage, mean SOD-1 activity in trisomic brains was increased approximately 1.5-fold in both trisomic fetal brains at days 14 and 17 of gestation and in whole trisomic fetuses at day 17. However, although the trisomy 16/diploid ratios of mean SOD-1 activities were close to 1.5, there was a sizable variance on each mean. To determine how much of this is attributable to other genetic and/or environmental factors, the SOD-1 activities of trisomic and diploid littermates were compared. As the data in Figure 2 demonstrate, the variation in SOD-1 activities within each pair of trisomic and matched diploid fetuses are closely correlated, with a correlation coefficient of 0.73 ( p = 0.001).
The levels of GSH-Px activity were not significantly different in gestational day 14 and 17 trisomic and diploid brains and in whole fetuses, with the specific activity being about 4.5-times greater in whole embryos than in brains. There was, however, a large variance within each group which could mask a small difference.
Lipidperoxidation in rnozue fetuses. Having demonstrated the increased SOD-1 activities in trisomic brains and whole fetuses, the levels of lipid peroxides, as measured by the production of MDA, were determined, and the results are shown in Table 2 .
The mean baseline levels of MDA were the same in day 17 trisomic and diploid fetal brains, while the levels found after incubation with heat, acid, and iron were, surprisingly, significantly decreased ( p < 0.001) in the trisomic brains.
SOD-1 and GSH-Px activities and lipid peroxidation in human trisomy 21 fibroblasts. A comparison of SOD-1 and GSH-Px activities and MDA formation after incubation with heat, ascorbic acid, and iron in matched sets of human trisomy 21 and diploid fibroblasts is shown in Table 3 . The mean SOD-1 activity in trisomic fibroblasts was increased approximately 1.5-fold ( p < 0.000 l), and the mean GSH-Px activity was increased by 1.18-fold ( p < 0.05). The mean baseline level of MDA was the same in trisomic and diploid fibroblasts, but the level observed after incubation with heat, acid, and iron was 1.55-fold increased ( p < 0.001) in the trisomy 2 1 fibroblasts.
DISCUSSION
The mean SOD-1 activity in trisomy 16 fetal mice is almost exactly 50% increased compared to that in the control fetuses, and mean SOD-1 activity in human trisomy 2 1 fibroblasts is also very close to 1.5-fold increased. These findings constitute yet another demonstration of the exactitude with which gene dosage effects operate (16) . In addition, these data further confirm the mapping of the SOD-1 gene to mouse chromosome 16. However, our data also suggest that other genetic and/or environmental components determine the levels of SOD-1 activity. There is considerable variance in the SOD-1 activity in whole fetuses, one genetic source of which could be the fact that neither the Robertsonian translocation-carrying males or the CD-1 females are inbred. However, the increased level of SOD-1 activity in individual trisomy 16 fetuses is very closely related to the level observed in their matched diploid littermates, an observation that is consistent with an earlier report (7) of a correlation between the GSH-Px activities in red cells of human trisomic 2 1 children and their diploid siblings.
We have observed an approximately 100% increase with age in the mean SOD-1 activity in brains of normal diploid mice. This increase occurs primarily during late gestation, and the SOD-1 activity reaches nearly the adult level by the time of birth. The mechanism underlying the increase in SOD-1 activity before birth and exposure to an external oxygen challenge is unknown. A similar observation was recently made on GSH-Px activities in rat lung (36) . Our finding that the SOD-1 activity in mouse brain changes very little during the first month after birth is in accord with the study of Kellogg and Fridovich (37), although they did observe an approximately 2-fold increase between 1 and 2 months of age (in A/J and LP/J mice). The constant GSH-Px activity after birth is consistent with findings in postnatal rat brains (38) , but once again there was an increase in SOD-1 activity during the 2nd month of life.
The maturation patterns of SOD-1 and GSH-Px do not follow the same pattern in all organs. Gerdin et al. (36) have recently reported a 135% increase of GSH-Px in rat lung perinatally, while the SOD-1 activity only increased by 53% during the same developmental period. They also reported that the periods of increase of SOD-1, GSH-Px, and catalase were not coordinated in time. Differences in the maturation patterns between SOD-1 and GSH-Px systems thus result in altered SOD-l/GSH-Px ratios in cytoplasm at different developmental stages, a result that indicates that the activity of GSH-Px is not necessarily linked to that of SOD-1. There are, unfortunately, no published data concerning the maturation of these two enzyme systems in human brains.
Despite the 1 S-fold increased SOD-1 activity in the brains of trisomy 16 mice, the mean GSH-Px activity was not found to be significantly increased. This result is the same as that reported for human fetal trisomy 2 1 brain by Brooksbank and Balazs (4) . However, in contrast to the further results of these investigators, who found an increased level of lipid peroxidation in the human trisomic brains, we found a decreased level. These findings suggest that an elevation in SOD-1 activity is not necessarily accompanied by either an induction of GSH-Px or an increased level of lipid peroxidation. Why then are the human and mouse data different regarding the latter? The leading possibility is that there are structural differences in the brain lipids which provide the substrate for lipid peroxidation. Thus, as has already been mentioned, Brooksbank et aal. (14) have noted an altered pattern of PUFA which could make them more susceptible to lipid peroxidation. Similarly, there may be other genetic or developmental differences between humans and mice which could affect the process. In this regard it is important to realize that mouse chromosome 16 is larger than human chromosome 21 and carries genes that are not present on the latter. Therefore, while SOD-1 activity is similarly increased in both the mouse and human trisomies, other loci may be differential affected in the two species.
A third possibility is that it is a matter of time, with the gestational period of the mouse being too short, especially in view of the relatively low oxygen tensions in fetal tissues, to AND EPSTElN permit the accumulation of significant amounts of lipid peroxides. This would not, however, explain why lipid peroxidation in the fetal trisomic mouse brains was less than normal, unless there were other biochemical differences (such as in lipid composition) between diploid and trisomic fetal brain or the increased SOD-1 activity serves, in this case, to protect the animal against lipid peroxidation. Such an increased protection is what ordinarily would be expected if SOD-I really did play a protective role against the deleterious effects of 0 2 -.
The results for GSH-Px in trisomic fetal brain, both human and mouse, and for the whole fetal mouse are at variance with what has been reported for other tissues. As has been mentioned in the introduction, several investigators have observed an increased GSH-Px activity in human trisomic cells, and we have also found a modest increase in our trisomy 21 fibroblasts coupled with an increased level of lipid peroxidation. The reason for this discrepancy between the results in brain and in the other tissues is not clear. One possibility is that GSH-Px is not inducible in the brain, but this would probably not apply to the whole mouse fetus. Another possibility is that the oxygen tension in fetal brain and possibly in the whole fetus is not high enough to trigger the inductive process. While the time required for induction could be an issue in the fetal mouse, this would certainly not apply to the human fetal brain. However, whatever the explanation, our results and those of Brooksband and Balazs (4) indicate, as has already been stated, that increased SOD-1 activity is not necessarily accompanied by an increase in GSH-Px activity.
Because of the possible role of a low tissue oxygen tension in the mouse fetuses in the results obtained, we attempted to stress the system. Accordingly, pregnant mice were put in 95% O2 during days 1 1 to 17 of gestation or were exposed, during the same gestational period, to paraquat, a potent superoxide generator, in the drinking water (at a dose of 250 ppm). In the latter experiment some of the pregnant mice died, but in neither of these two trials did lipid peroxidation or the GSH-Px activity change in the brains of either the pregnant mice or of their trisomy 16 or diploid fetuses.
Our findings with the trisomy 16 mouse fetus do not lend any support to the notion that increased SOD-1 activity is developmentally deleterious. However, it is clear that a limitation of these studies is the fact that we are restricted to the fetal period. Work is now in progress, therefore, to develop transgenic mice with elevated SOD-1 activities which can be used to delineate further the relationships between SOD-1 activity, GSH-Px activity, and lipid peroxidation.
